Home > Insider Trading > Filing (0001209191-21-059698)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645460	Cue Biopharma Inc.	CUE	Pharmaceutical Preparations (2834)	473324577

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1739126	Kerri-Ann Millar	C/O Cue Biopharma Inc. 21 Erie Street Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-08-23	6,667	$0.00	12,433	No	4	M	Direct
Common Stock	Disposition	2021-08-23	1,961	$0.00	10,472	No	4	F	Direct
Common Stock	Acquisiton	2021-10-01	1,251	$7.50	11,723	No	4	M	Direct
Common Stock	Disposition	2021-10-01	1,251	$14.21	10,472	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-08-23	6,667	$0.00	6,667	$0.00
Common Stock	Stock Option (right to buy)	Disposition	2021-10-01	1,251	$0.00	1,251	$7.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,667			No	4	M	Direct
53,749		2024-12-27	No	4	M	Direct

Footnotes

Represents shares of common stock received upon vesting of a restricted stock unit award.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $14.46, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.
Each restricted stock unit award represents a contingent right to receive one share of common stock.
Represents a restricted stock unit award granted on August 21, 2020. The restricted stock units vest in three equal annual installments beginning on August 21, 2020.
The option vests in eight equal semi-annual installments beginning March 25, 2018.